Its like a seed, dormant and protected
We ensure there are no unnecessary synthetic fillers and that our sourcing is non-GMO and organic where possible
When tesamorelin is the more appropriate choice Tesamorelin is typically the preferred agent when: Visceral adipose tissue is the primary treatment target, particularly with associated metabolic comorbidities A clinician is working within a framework that prioritises FDA-approved agents The patient has HIV-associated lipodystrophy, the only approved indication A robust evidence base is required for clinical decision-making For general somatopause-related concerns gradual changes in body composition, sleep quality, and recovery the CJC-1295/ipamorelin combination remains more commonly used, primarily because of its flexible dosing profile and the preserved pulsatile GH release pattern
This approach maintains hydration while making water consumption more appealing for patients who struggle with plain water
Step-by-Step Reconstitution Step 1: Clean Everything Protocols describe wiping the tops of both vials (MOTS-C and BAC water) with alcohol swabs, then letting them air dry for 10 seconds
Each bundle includes: Two pre-calibrated research pens 20mg research peptide per pen 40mg total research compound Precision pre-calibrated delivery mechanism Ready-to-use laboratory format Secure tamper-evident construction Clearly labelled Research Use Only packaging Batch identification and traceability No reconstitution required The dual-pen configuration helps laboratories maintain consistency throughout multiple research phases while reducing preparation time